scholarly article | Q13442814 |
P8978 | DBLP publication ID | journals/jcisd/TruchonB07 |
P356 | DOI | 10.1021/CI600426E |
P698 | PubMed publication ID | 17288412 |
P2093 | author name string | Christopher I Bayly | |
Jean-François Truchon | |||
P433 | issue | 2 | |
P921 | main subject | virtual screening | Q4112105 |
P304 | page(s) | 488-508 | |
P577 | publication date | 2007-02-09 | |
P1433 | published in | Journal of Chemical Information and Modeling | Q3007982 |
P1476 | title | Evaluating virtual screening methods: good and bad metrics for the "early recognition" problem. | |
P478 | volume | 47 |
Q42868907 | 4D Flexible Atom-Pairs: An efficient probabilistic conformational space comparison for ligand-based virtual screening |
Q42318149 | A Bayesian Target Predictor Method based on Molecular Pairing Energies estimation. |
Q33551124 | A CROC stronger than ROC: measuring, visualizing and optimizing early retrieval. |
Q90642490 | A Distance-Based Boolean Applicability Domain for Classification of High Throughput Screening Data |
Q48298528 | A Molecular Dynamics-Shared Pharmacophore Approach to Boost Early-Enrichment Virtual Screening: A Case Study on Peroxisome Proliferator-Activated Receptor α. |
Q103831973 | A Multi-Objective Approach for Anti-Osteosarcoma Cancer Agents Discovery through Drug Repurposing |
Q64922722 | A New Pharmacophore Model for the Design of Sigma-1 Ligands Validated on a Large Experimental Dataset. |
Q50114279 | A desirability-based multi objective approach for the virtual screening discovery of broad-spectrum anti-gastric cancer agents. |
Q57457333 | A facile consensus ranking approach enhances virtual screening robustness and identifies a cell-active DYRK1α inhibitor |
Q36804305 | A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi |
Q42675961 | A novel and efficient ligand-based virtual screening approach using the HWZ scoring function and an enhanced shape-density model |
Q51543578 | A novel, customizable and optimizable parameter method using spherical harmonics for molecular shape similarity comparisons. |
Q33484416 | A statistical framework to evaluate virtual screening |
Q53638590 | A steered molecular dynamics mediated hit discovery for histone deacetylases. |
Q39842778 | Adapting Document Similarity Measures for Ligand-Based Virtual Screening. |
Q37549101 | All-atom/coarse-grained hybrid predictions of distribution coefficients in SAMPL5. |
Q36043433 | An Algorithm to Identify Target-Selective Ligands - A Case Study of 5-HT7/5-HT1A Receptor Selectivity |
Q27998664 | Application of 3D Zernike descriptors to shape-based ligand similarity searching |
Q34019272 | Application of NMR and molecular docking in structure-based drug discovery |
Q30539786 | Automated design of ligands to polypharmacological profiles. |
Q59254334 | Automatic pharmacophore model generation using weighted substructure assignments |
Q92134160 | Bayesian semi-supervised learning for uncertainty-calibrated prediction of molecular properties and active learning |
Q27902269 | Benchmark of four popular virtual screening programs: construction of the active/decoy dataset remains a major determinant of measured performance |
Q39094539 | Benchmarking of multivariate similarity measures for high-content screening fingerprints in phenotypic drug discovery |
Q50593408 | Best Matching Protein Conformations and Docking Programs for a Virtual Screening Campaign Against SMO Receptor. |
Q41093798 | Best of both worlds: on the complementarity of ligand-based and structure-based virtual screening |
Q42695674 | Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set. |
Q42639520 | Bias, reporting, and sharing: computational evaluations of docking methods |
Q38910044 | Bioisosteric Replacement and Scaffold Hopping in Lead Generation and Optimization |
Q26864619 | Blind prediction of HIV integrase binding from the SAMPL4 challenge |
Q39525827 | CS-MINER: A Tool for Association Mining in Binding-Database |
Q27902293 | Calculating an optimal box size for ligand docking and virtual screening against experimental and predicted binding pockets |
Q28484330 | Can the energy gap in the protein-ligand binding energy landscape be used as a descriptor in virtual ligand screening? |
Q55401605 | Cascade Ligand- and Structure-Based Virtual Screening to Identify New Trypanocidal Compounds Inhibiting Putrescine Uptake. |
Q37094597 | Chemically Advanced Template Search (CATS) for Scaffold-Hopping and Prospective Target Prediction for 'Orphan' Molecules |
Q36250876 | Chemoinformatics Profiling of the Chromone Nucleus as a MAO-B/A2AAR Dual Binding Scaffold. |
Q91343873 | Chemoinformatics and structural bioinformatics in OCaml |
Q47116087 | Combined Virtual and Experimental Screening for CK1 Inhibitors Identifies a Modulator of p53 and Reveals Important Aspects of in Silico Screening Performance |
Q35054899 | Combining on-chip synthesis of a focused combinatorial library with computational target prediction reveals imidazopyridine GPCR ligands |
Q35783103 | Comparative Analysis of Virtual Screening Approaches in the Search for Novel EphA2 Receptor Antagonists. |
Q100503937 | Comparative study between deep learning and QSAR classifications for TNBC inhibitors and novel GPCR agonist discovery |
Q28292041 | Comparing neural-network scoring functions and the state of the art: applications to common library screening |
Q27902270 | Comparing structural fingerprints using a literature-based similarity benchmark |
Q92178374 | Comparison of Data Fusion Methods as Consensus Scores for Ensemble Docking |
Q39909719 | Comparison of structure fingerprint and molecular interaction field based methods in explaining biological similarity of small molecules in cell-based screens |
Q60238441 | Compound Ranking Based on Fuzzy Three-Dimensional Similarity Improves the Performance of Docking into Homology Models of G-Protein-Coupled Receptors |
Q30393891 | Comprehensive structural and functional characterization of the human kinome by protein structure modeling and ligand virtual screening |
Q31155333 | Computational redesign of bacterial biotin carboxylase inhibitors using structure-based virtual screening of combinatorial libraries. |
Q39198542 | Condorcet and borda count fusion method for ligand-based virtual screening |
Q34440071 | Consensus Induced Fit Docking (cIFD): methodology, validation, and application to the discovery of novel Crm1 inhibitors |
Q33530647 | Consensus model for identification of novel PI3K inhibitors in large chemical library |
Q38430192 | Consensus strategy in genes prioritization and combined bioinformatics analysis for preeclampsia pathogenesis |
Q56980280 | Deep learning and virtual drug screening |
Q90633197 | Design and Selection of Novel C1s Inhibitors by In Silico and In Vitro Approaches |
Q90656648 | Development of New Methods Needs Proper Evaluation-Benchmarking Sets for Machine Learning Experiments for Class A GPCRs |
Q34785475 | Development of a highly selective allosteric antagonist radioligand for the type 1 cholecystokinin receptor and elucidation of its molecular basis of binding |
Q37105057 | Development of conformation independent computational models for the early recognition of breast cancer resistance protein substrates. |
Q28553112 | Discovery of Novel Hepatitis C Virus NS5B Polymerase Inhibitors by Combining Random Forest, Multiple e-Pharmacophore Modeling and Docking |
Q52590808 | Discovery of Novel Inhibitors of Indoleamine 2,3-Dioxygenase 1 Through Structure-Based Virtual Screening. |
Q58880968 | Discovery of Novel Molecular Frameworks of Farnesoid X Receptor Modulators by Ensemble Machine Learning |
Q35172930 | Discovery of binding proteins for a protein target using protein-protein docking-based virtual screening |
Q34707685 | Diversity selection of compounds based on 'protein affinity fingerprints' improves sampling of bioactive chemical space |
Q34049826 | Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening? |
Q36098710 | Docking and scoring with ICM: the benchmarking results and strategies for improvement |
Q39096521 | Docking to multiple pockets or ligand fields for screening, activity prediction and scaffold hopping |
Q61815750 | Drug-induced diabetes type 2: In silico study involving class B GPCRs |
Q86706640 | Dynamics and structural determinants of ligand recognition of the 5-HT6 receptor |
Q36053324 | E-pharmacophore-based virtual screening to identify GSK-3β inhibitors |
Q27304699 | Efficient and biologically relevant consensus strategy for Parkinson's disease gene prioritization. |
Q55669060 | Endocrine Disruption at the Androgen Receptor: Employing Molecular Dynamics and Docking for Improved Virtual Screening and Toxicity Prediction. |
Q30585969 | Enhanced ranking of PknB Inhibitors using data fusion methods |
Q42320200 | Enhancing Virtual Screening Performance of Protein Kinases with Molecular Dynamics Simulations |
Q50940415 | Enhancing the Reliability of GPCR Models by Accounting for Flexibility of Their Pro-Containing Helices: the Case of the Human mAChR1 Receptor. |
Q30959752 | Enrichment assessment of multiple virtual screening strategies for Toll-like receptor 8 agonists based on a maximal unbiased benchmarking data set. |
Q39951742 | Estimation of the applicability domain of kernel-based machine learning models for virtual screening |
Q30367162 | Evaluating docking programs: keeping the playing field level. |
Q37518530 | Evaluation of DOCK 6 as a pose generation and database enrichment tool |
Q27998703 | Evaluation of a Bayesian inference network for ligand-based virtual screening |
Q37057393 | Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection--what can we learn from earlier mistakes? |
Q36548489 | Exploration of multiple Sortase A protein conformations in virtual screening |
Q86018664 | Exploring conformational search protocols for ligand-based virtual screening and 3-D QSAR modeling |
Q42874590 | Exploring different virtual screening strategies for acetylcholinesterase inhibitors |
Q55309100 | Extending in Silico Protein Target Prediction Models to Include Functional Effects. |
Q27902259 | Filtered circular fingerprints improve either prediction or runtime performance while retaining interpretability |
Q38574930 | Flexible receptor docking for drug discovery |
Q39380258 | From flamingo dance to (desirable) drug discovery: a nature-inspired approach |
Q48875877 | Fusing Docking Scoring Functions Improves the Virtual Screening Performance for Discovering Parkinson's Disease Dual Target Ligands. |
Q30437388 | GPCR 3D homology models for ligand screening: lessons learned from blind predictions of adenosine A2a receptor complex |
Q47573321 | GalaxyDock2: protein-ligand docking using beta-complex and global optimization |
Q55431831 | Gene prioritization using Bayesian matrix factorization with genomic and phenotypic side information. |
Q91763848 | Getting Docking into Shape Using Negative Image-Based Rescoring |
Q61925358 | Glossary of terms used in computational drug design, part II (IUPAC Recommendations 2015) |
Q96018100 | High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment |
Q27000720 | Hit identification and optimization in virtual screening: practical recommendations based on a critical literature analysis |
Q35676486 | Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification. |
Q54110122 | How to Achieve Better Results Using PASS-Based Virtual Screening: Case Study for Kinase Inhibitors. |
Q59075291 | Identification of levothyroxine antichagasic activity through computer-aided drug repurposing |
Q35003819 | Identification of new natural DNA G-quadruplex binders selected by a structure-based virtual screening approach. |
Q38771000 | Identification of potential inhibitors for HCV NS3 genotype 4a by combining protein-ligand interaction fingerprint, 3D pharmacophore, docking, and dynamic simulation |
Q34219538 | Identification of selective inhibitors of the potassium channel Kv1.1-1.2((3)) by high-throughput virtual screening and automated patch clamp |
Q38720041 | Identifying ligands at orphan GPCRs: current status using structure-based approaches |
Q93362283 | Implicit-descriptor ligand-based virtual screening by means of collaborative filtering |
Q89174818 | Improving Prediction Accuracy of Binding Free Energies and Poses of HIV Integrase Complexes Using the Binding Energy Distribution Analysis Method with Flattening Potentials |
Q90049923 | Improving the Virtual Screening Ability of Target-Specific Scoring Functions Using Deep Learning Methods |
Q64251945 | In Silico Evaluation of Ibuprofen and Two Benzoylpropionic Acid Derivatives with Potential Anti-Inflammatory Activity |
Q92860146 | In silico Guided Drug Repurposing: Discovery of New Competitive and Non-competitive Inhibitors of Falcipain-2 |
Q42010190 | In silico predictive model to determine vector-mediated transport properties for the blood-brain barrier choline transporter |
Q93143025 | Influence of the Structural Accuracy of Homology Models on Their Applicability to Docking-Based Virtual Screening: The β2 Adrenergic Receptor as a Case Study |
Q37360048 | Influence relevance voting: an accurate and interpretable virtual high throughput screening method |
Q36496151 | Inhibiting Helicobacter pylori HtrA protease by addressing a computationally predicted allosteric ligand binding site |
Q35932496 | Inhibitor design against JNK1 through e-pharmacophore modeling docking and molecular dynamics simulations. |
Q28477589 | Inhibitors of Helicobacter pylori protease HtrA found by 'virtual ligand' screening combat bacterial invasion of epithelia |
Q39537370 | Integrated One-Against-One Classifiers as Tools for Virtual Screening of Compound Databases: A Case Study with CNS Inhibitors |
Q35836731 | Integrating sampling techniques and inverse virtual screening: toward the discovery of artificial peptide-based receptors for ligands |
Q60950229 | Inverse Molecular Docking as a Novel Approach to Study Anticarcinogenic and Anti-Neuroinflammatory Effects of Curcumin |
Q90193662 | Key Topics in Molecular Docking for Drug Design |
Q45964832 | LASSO-ligand activity by surface similarity order: a new tool for ligand based virtual screening. |
Q27998705 | Large scale study of multiple-molecule queries |
Q51556600 | Large-scale computational drug repositioning to find treatments for rare diseases. |
Q92669772 | Ligand-Based Virtual Screening Using Graph Edit Distance as Molecular Similarity Measure |
Q34225364 | Ligand-based virtual screening approach using a new scoring function |
Q36316392 | Ligand-guided homology modelling of the GABAB2 subunit of the GABAB receptor |
Q44789723 | Ligand-guided optimization of CXCR4 homology models for virtual screening using a multiple chemotype approach. |
Q92221080 | Ligity: A Non-Superpositional, Knowledge-Based Approach to Virtual Screening |
Q112615808 | MAIP: a web service for predicting blood-stage malaria inhibitors |
Q90433761 | MBLinhibitors.com, a Website Resource Offering Information and Expertise for the Continued Development of Metallo--Lactamase Inhibitors |
Q57832782 | MOLECULAR SIMILARITY ANALYSIS |
Q62495870 | Machine Learning-based Virtual Screening and Its Applications to Alzheimer's Drug Discovery: A Review |
Q26750642 | Machine-learning scoring functions to improve structure-based binding affinity prediction and virtual screening |
Q53033714 | Managing bias in ROC curves. |
Q54572862 | Mapping the 3D structures of small molecule binding sites. |
Q36138895 | Matrix-based Molecular Descriptors for Prospective Virtual Compound Screening |
Q50320785 | Maximizing gain in high-throughput screening using conformal prediction. |
Q45943415 | Methods for Virtual Screening of GPCR Targets: Approaches and Challenges. |
Q91657657 | Molecular Architect: A User-Friendly Workflow for Virtual Screening |
Q92989414 | Molecular Informatics Studies of the Iron-Dependent Regulator (ideR) Reveal Potential Novel Anti-Mycobacterium ulcerans Natural Product-Derived Compounds |
Q36683781 | Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric Complex. |
Q27659860 | Molecular Shape and Medicinal Chemistry: A Perspective |
Q37175130 | Molecular basis for benzodiazepine agonist action at the type 1 cholecystokinin receptor. |
Q36002904 | Molecular basis for binding and subtype selectivity of 1,4-benzodiazepine antagonist ligands of the cholecystokinin receptor |
Q38828100 | Molecular graph convolutions: moving beyond fingerprints. |
Q92373356 | Multi-Level Comparison of Machine Learning Classifiers and Their Performance Metrics |
Q39535413 | Multiple e-Pharmacophore Modeling Combined with High-Throughput Virtual Screening and Docking to Identify Potential Inhibitors of β-Secretase(BACE1). |
Q80697151 | Multiple protein structures and multiple ligands: effects on the apparent goodness of virtual screening results |
Q63849411 | Multivariate class modeling for the verification of food-authenticity claims |
Q110391837 | Natural product drug discovery in the artificial intelligence era |
Q57175754 | Netpredictor: R and Shiny package to perform drug-target network analysis and prediction of missing links |
Q48105075 | Novel Bacterial Topoisomerase Inhibitors Exploit Asp83 and the Intrinsic Flexibility of the DNA Gyrase Binding Site. |
Q28681290 | Open-source platform to benchmark fingerprints for ligand-based virtual screening |
Q27998698 | Optimal assignment methods for ligand-based virtual screening |
Q34637014 | Optimization and visualization of the edge weights in optimal assignment methods for virtual screening |
Q36343219 | Optimization of adenosine 5'-carboxamide derivatives as adenosine receptor agonists using structure-based ligand design and fragment screening |
Q27902299 | Optimizing drug–target interaction prediction based on random walk on heterogeneous networks |
Q62629057 | Orphan Drug Legislation with Data Fusion Rules Using Multiple Fingerprints Measurements |
Q42696820 | Orthologue chemical space and its influence on target prediction |
Q39513411 | PL-PatchSurfer2: Improved Local Surface Matching-Based Virtual Screening Method That Is Tolerant to Target and Ligand Structure Variation |
Q35668928 | Pathway-Dependent Effectiveness of Network Algorithms for Gene Prioritization |
Q36092217 | Pharmacophore Alignment Search Tool (PhAST): Significance Assessment of Chemical Similarity |
Q60932853 | Pharmacophore Modeling, Synthesis, and Antibacterial Evaluation of Chalcones and Derivatives |
Q33822689 | Pharmacophore alignment search tool: influence of scoring systems on text-based similarity searching |
Q33822695 | Pharmacophore alignment search tool: influence of the third dimension on text-based similarity searching |
Q57458404 | Pharmacophore modeling, docking and molecular dynamics to identify Leishmania major farnesyl pyrophosphate synthase inhibitors |
Q47587655 | Pharmacophore modelling, virtual screening and molecular docking studies on PLD1 inhibitors. |
Q36087114 | Pharmacophores in Drug Research. |
Q61809823 | Potential off-target effects of beta-blockers on gut hormone receptors: In silico study including GUT-DOCK-A web service for small-molecule docking |
Q59807525 | PotentialNet for Molecular Property Prediction |
Q89993923 | Practical Model Selection for Prospective Virtual Screening |
Q28604323 | Predicting drug target interactions using meta-path-based semantic network analysis |
Q36960746 | Predicting protein interactions via parsimonious network history inference |
Q43124392 | Predictions of hydration free energies from all-atom molecular dynamics simulations. |
Q27902344 | Predictiveness curves in virtual screening |
Q36087023 | Prioritizing Hits with Appropriate Trade-Offs Between HIV-1 Reverse Transcriptase Inhibitory Efficacy and MT4 Blood Cells Toxicity Through Desirability-Based Multiobjective Optimization and Ranking |
Q92811723 | Probabilistic Approach for Virtual Screening Based on Multiple Pharmacophores |
Q48498363 | Progress towards automated Kepler scientific workflows for computer-aided drug discovery and molecular simulations. |
Q44012277 | Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments |
Q33517871 | Protein-protein docking using region-based 3D Zernike descriptors |
Q112621355 | QSAR-derived affinity fingerprints (part 1): fingerprint construction and modeling performance for similarity searching, bioactivity classification and scaffold hopping |
Q57814810 | Quantitative and systems pharmacology 4. Network-based analysis of drug pleiotropy on coronary artery disease |
Q36795631 | Rational prediction with molecular dynamics for hit identification |
Q34204731 | Recognizing pitfalls in virtual screening: a critical review |
Q64949997 | Rescoring and Linearly Combining: A Highly Effective Consensus Strategy for Virtual Screening Campaigns. |
Q55093753 | Reverse Screening Methods to Search for the Protein Targets of Chemopreventive Compounds. |
Q45963765 | Robust optimization of scoring functions for a target class. |
Q27902277 | Rocker: Open source, easy-to-use tool for AUC and enrichment calculations and ROC visualization |
Q90559172 | STarFish: A Stacked Ensemble Target Fishing Approach and its Application to Natural Products |
Q57976067 | Shape-based similarity searching in chemical databases |
Q34076210 | Shape-based virtual screening with volumetric aligned molecular shapes |
Q39901298 | Small molecule hydration free energies in explicit solvent: An extensive test of fixed-charge atomistic simulations |
Q43730054 | Solvation free energies and partition coefficients with the coarse-grained and hybrid all-atom/coarse-grained MARTINI models. |
Q28479435 | Spherical harmonics coefficients for ligand-based virtual screening of cyclooxygenase inhibitors |
Q41930155 | Structure based Virtual Screening toward the discovery of novel inhibitors for impeding the protein-protein interaction between HIV-1 integrase and human lens epithelium-derived growth factor (LEDGF/p75). |
Q56854167 | Structure based virtual screening to discover putative drug candidates: Necessary considerations and successful case studies |
Q30435017 | Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists |
Q33934472 | Structure-based virtual screening of glycogen synthase kinase 3β inhibitors: analysis of scoring functions applied to large true actives and decoy sets. |
Q28478200 | Systematic exploitation of multiple receptor conformations for virtual ligand screening |
Q39169235 | Systemic QSAR and phenotypic virtual screening: chasing butterflies in drug discovery |
Q28745255 | The power metric: a new statistically robust enrichment-type metric for virtual screening applications with early recovery capability |
Q35571453 | The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets |
Q26801796 | Three-dimensional compound comparison methods and their application in drug discovery |
Q51099469 | Toward the computer-aided discovery of FabH inhibitors. Do predictive QSAR models ensure high quality virtual screening performance? |
Q37014096 | Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go. |
Q30383112 | Ultra-High-Throughput Structure-Based Virtual Screening for Small-Molecule Inhibitors of Protein-Protein Interactions. |
Q28307816 | Ultrafast shape recognition: method and applications |
Q30432445 | Unleashing the power of meta-threading for evolution/structure-based function inference of proteins |
Q47306187 | Unravelling novel congeners from acetyllysine mimicking ligand targeting a lysine acetyltransferase PCAF bromodomain |
Q37459651 | Validation of molecular docking programs for virtual screening against dihydropteroate synthase |
Q36095634 | Variability in docking success rates due to dataset preparation |
Q51900328 | Virtual screening applications: a study of ligand-based methods and different structure representations in four different scenarios. |
Q52589878 | Virtual screening by a new Clustering-based Weighted Similarity Extreme Learning Machine approach. |
Q28475016 | Virtual screening for HIV protease inhibitors: a comparison of AutoDock 4 and Vina |
Q51475792 | Virtual screening for compounds that mimic protein-protein interface epitopes. |
Q34626368 | Virtual screening of chemical libraries for drug discovery |
Q30481529 | What do we know and when do we know it? |
Q39531365 | eFindSite: Enhanced Fingerprint-Based Virtual Screening Against Predicted Ligand Binding Sites in Protein Models |
Q27902311 | vSDC: a method to improve early recognition in virtual screening when limited experimental resources are available |
Search more.